Marker Therapeutics, Inc. (MRKR) › Operating IncomeMarker Therapeutics, Inc. (MRKR) — Operating IncomeAnnual figures by period end, from SEC filings.2010-12-31: -$5.47M2013-12-31: -$2.66M2014-12-31: -$3.37M2015-12-31: -$6.16M2016-12-31: -$8.49M2017-12-31: -$11.48M2018-12-31: -$148.17M2019-12-31: -$22.53M2020-12-31: -$28.89M2021-12-31: -$39.48M2022-12-31: -$19.79M2023-12-31: -$14.58M2024-12-31: -$11.12M2025-12-31: -$12.89M-$12.89M2010-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$12.89M—2026-03-18From 2025-01-012024-12-31-$11.12M—2026-03-18From 2024-01-012023-12-31-$14.58M—2025-03-31From 2023-01-012022-12-31-$19.79M—2024-03-26From 2022-01-012021-12-31-$39.48M—2023-03-22From 2021-01-012020-12-31-$28.89M—2022-03-17From 2020-01-012019-12-31-$22.53M—2021-03-09From 2019-01-012018-12-31-$148.17M—2020-03-12From 2018-01-012017-12-31-$11.48M—2019-03-15From 2017-01-012016-12-31-$8.49M—2018-03-23From 2016-01-012015-12-31-$6.16M—2017-03-14From 2015-01-012014-12-31-$3.37M—2016-04-14From 2014-01-012013-12-31-$2.66M—2015-04-15From 2013-01-012010-12-31-$5.47M—2012-04-16From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)